Spearhead Capital Advisors, LLC Ocular Therapeutix, Inc Transaction History

Spearhead Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$4.83 - $7.35 $117,383 - $178,627	-24,303 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$6.16 - $12.07 $2,297 - $4,502	373 Added 1.56%	24,303 $169,000
Q3 2021 Oct 27, 2021	SELL	$9.7 - $14.34 $1,978 - $2,925	-204 Reduced 0.85%	23,930 $239,000
Q2 2021 Aug 10, 2021	BUY	$13.43 - $19.16 $51,745 - $73,823	3,853 Added 19.0%	24,134 $342,000
Q1 2021 Apr 28, 2021	BUY	$15.82 - $22.11 $320,845 - $448,412	20,281 New	20,281 $333,000

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $643M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.